High circulating tumor DNA (ctDNA) concentration was associated with shorter progression free survival in patients with metastatic breast cancer

被引:0
作者
Yi, Hanbaek
Kim, Tae-Yong
Song, Myung Geun
Kim, Hwang-Phill
Kim, Tae-You
Kim, Jinyong
Lee, Dae-Won
Lee, Kyung-Hun
Im, Seock-Ah
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO2-13-11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO2-13-11
引用
收藏
页数:3
相关论文
共 50 条
[41]   Circulating tumor cells in metastatic breast cancer: Are they a strong and independent predictor of poor progression-free and overall survival? [J].
Wallwiener, Markus ;
Schneeweiss, Andreas ;
Baccelli, Irene ;
Riethdorf, Sabine ;
Pantel, Klaus ;
Marme, Frederik ;
Schott, Sarah ;
Trumpp, Andreas ;
Taran, Florin-Andrei ;
Hahn, Markus ;
Schuetz, Florian ;
Mueller, Volkmar ;
Rack, Brigitte Kathrin ;
Sohn, Christof ;
Solomayer, Erich-Franz ;
Janni, Wolfgang ;
Hartkopf, Andreas D. ;
Fehm, Tanja N. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[42]   Circulating HER2 extracellular domain (ECD) levels are associated with progression-free survival in metastatic breast cancer patients [J].
Wang, X-J ;
Shao, X-Y ;
Chen, Z-H ;
Ye, W-W ;
Qin, J. ;
Zhang, Y- M. ;
Zheng, Y-B ;
Yu, X-Y ;
Lei, L. ;
Ling, Z-Q ;
Feng, J-G ;
Han, M. X. .
CANCER RESEARCH, 2012, 72
[43]   Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer [J].
Martens, G. A. ;
Demol, J. ;
Dedeurwaerdere, F. ;
Breyne, J. ;
De Smet, K. ;
De Jaeger, P. ;
De Smet, D. .
ESMO OPEN, 2024, 9 (02)
[44]   The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA [J].
Liu, Binliang ;
Hu, Zheyu ;
Ran, Jialu ;
Xie, Ning ;
Tian, Can ;
Tang, Yu ;
Ouyang, Quchang .
BREAST, 2022, 65 :116-123
[45]   Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer [J].
Cheng, Jie ;
Holland-Letz, Tim ;
Wallwiener, Markus ;
Surowy, Harald ;
Cuk, Katarina ;
Schott, Sarah ;
Trumpp, Andreas ;
Pantel, Klaus ;
Sohn, Christof ;
Schneeweiss, Andreas ;
Burwinkel, Barbara .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (01) :69-82
[46]   Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer [J].
Jie Cheng ;
Tim Holland-Letz ;
Markus Wallwiener ;
Harald Surowy ;
Katarina Cuk ;
Sarah Schott ;
Andreas Trumpp ;
Klaus Pantel ;
Christof Sohn ;
Andreas Schneeweiss ;
Barbara Burwinkel .
Breast Cancer Research and Treatment, 2018, 169 :69-82
[47]   Circulating Tumor DNA to Monitor Metastatic Breast Cancer [J].
Weiss, Lukas ;
Hufnagl, Clemens ;
Greil, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :93-93
[48]   CIRCULATING TUMOR DNA IS A BIOMARKER OF METASTATIC BREAST CANCER [J].
不详 .
CANCER DISCOVERY, 2013, 3 (05) :482-482
[49]   Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in eary high risk breast cancer: The CITUCEL trial update [J].
Borea, R. ;
Cardinali, B. ;
Arecco, L. ;
De Luca, G. ;
Garuti, A. ;
Mazzitelli, C. ;
Sciutto, A. ;
Poggio, F. ;
Conte, B. ;
Buzzatti, G. ;
Blondeaux, E. ;
Carli, F. ;
Anselmi, G. ;
Profumo, A. ;
Coronel-Vargas, G. F. ;
Ballestrero, A. ;
Ferrando, L. ;
Zoppoli, G. ;
Dono, M. ;
Del Mastro, L. .
ANNALS OF ONCOLOGY, 2024, 35 :S247-S247
[50]   The use of circulating tumor DNA (ctDNA) in HER2+metastatic breast cancer (MBC) for prognostication and management [J].
Warrior, Surbhi ;
Jaber, Diana ;
Heater, Natalie ;
Marini, Sarah ;
Ma, Yangruijue ;
Sun, Zequn ;
Flaum, Lisa ;
Robinson, Patricia ;
Stein, Regina ;
Stein, Regina ;
Cristofanilli, Massimo ;
Gradishar, William ;
Lu, Janice .
CANCER RESEARCH, 2025, 85 (08)